In this study, we have analyzed human primary lung adenocarcinoma tumors using global mass spectrometry to elucidate the biological mechanisms behind relapse post surgery. In total, we identified over 3000 proteins with high confidence. Supervised multivariate analysis was used to select 132 proteins separating the prognostic groups. Based on in-depth bioinformatics analysis, we hypothesized that the tumors with poor prognosis had a higher glycolytic activity and HIF activation. By measuring the bioenergetic cellular index of the tumors, we could detect a higher dependency of glycolysis among the tumors with poor prognosis. Further, we could also detect an up-regulation of HIF1α mRNA expression in tumors with early relapse. Finally, we sele...
Lung cancer is the leading cause of cancer death in men and women in Western nations, and is among t...
Abstract Background Non-small cell lung carcinoma (NSCLC) remains the leading cause of cancer deaths...
Patients with head‐and‐neck cancer can develop both lung metastasis and primary lung cancer during t...
In this study, we have analyzed human primary lung adenocarcinoma tumors using global mass spectrome...
Lung cancer is one of the most common cancers worldwide, and is the top cause of cancer-related deat...
BACKGROUND: A gel-free proteomic approach was utilized to perform in-depth tissue protein profiling ...
Lung adenocarcinomas often display a high degree of intratumoral heterogeneity as manifested both by...
BackgroundLung cancer is the leading cause of cancer mortality in the United States. Non-small cell ...
We attempted to identify prognosis-related proteins expressed in early resection lung adenocarcinoma...
Background: Brain metastases are associated with considerable negative effects on patients’ outcome ...
Lung cancer is the leading cause of preventable death globally and is broadly classified into adenoc...
In an effort to further our understanding of lung cancer biology and to identify new candidate bioma...
Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures...
IntroductionThe identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is...
Background: The most commonly reported primary lung cancer subtype is adenocarcinoma, which is assoc...
Lung cancer is the leading cause of cancer death in men and women in Western nations, and is among t...
Abstract Background Non-small cell lung carcinoma (NSCLC) remains the leading cause of cancer deaths...
Patients with head‐and‐neck cancer can develop both lung metastasis and primary lung cancer during t...
In this study, we have analyzed human primary lung adenocarcinoma tumors using global mass spectrome...
Lung cancer is one of the most common cancers worldwide, and is the top cause of cancer-related deat...
BACKGROUND: A gel-free proteomic approach was utilized to perform in-depth tissue protein profiling ...
Lung adenocarcinomas often display a high degree of intratumoral heterogeneity as manifested both by...
BackgroundLung cancer is the leading cause of cancer mortality in the United States. Non-small cell ...
We attempted to identify prognosis-related proteins expressed in early resection lung adenocarcinoma...
Background: Brain metastases are associated with considerable negative effects on patients’ outcome ...
Lung cancer is the leading cause of preventable death globally and is broadly classified into adenoc...
In an effort to further our understanding of lung cancer biology and to identify new candidate bioma...
Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures...
IntroductionThe identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is...
Background: The most commonly reported primary lung cancer subtype is adenocarcinoma, which is assoc...
Lung cancer is the leading cause of cancer death in men and women in Western nations, and is among t...
Abstract Background Non-small cell lung carcinoma (NSCLC) remains the leading cause of cancer deaths...
Patients with head‐and‐neck cancer can develop both lung metastasis and primary lung cancer during t...